Evaluation of Efficacy and Safety of Nicotine- Qbeta (NicQb) Vaccine versus Placebo in Healthy Smokers

Authors
Category Primary study
Year 2004
This will be a randomized Phase II efficacy and safety study with one dose of NicQb versus placebo, conducted according to a parallel-group, multi-center study design. At the first center starting the trial, the inclusion of subjects will be staggered such that the first 20 subjects must have completed visit 2 (7 days after the first injection) and tolerability shown to be good; then the additional subjects may be included as they are available and eligible.
Epistemonikos ID: 389ecd3ec76eb13af50c133f84b34e6f6b1182f3
First added on: Apr 09, 2013